Jaguar Health
JAGX
0 hedge funds and large institutions have $3.94M invested in Jaguar Health in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
380% more call options, than puts
Call options by funds: $197K | Put options by funds: $41K
0% less ownership
Funds ownership: 0% → 0% (-0%)
17% less capital invested
Capital invested by funds: $4.75M → $3.94M (-$810K)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.39M |
| 2 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$174K |
| 3 |
BSW
Buckingham Strategic Wealth
Clayton,
Missouri
|
-$33K |
| 4 |
LPL Financial
San Diego,
California
|
-$13K |
JAGX Hedge Fund Activity: Q1 2022 in Review
0 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q1 2022, worth a combined $3.94M — down 17% from $4.75M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of JAGX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $2.39M sold.
- 0 institutional investors held Jaguar Health (JAGX) as of Q1 2022, down from 1 in Q4 2021.
- Funds reported $3.94M of Jaguar Health stock for Q1 2022, down 17% quarter-over-quarter.
- 0 funds opened new Jaguar Health positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest Jaguar Health seller in Q1 2022 was Vanguard Group, an estimated $2.39M sold.
Based on aggregated 13F filings for Q1 2022.